-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
8 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$44.20 M
Intra-Cellular Therapies, Inc. Insider Transactions
Intra-Cellular Therapies, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Mates Sharon
CEO |
Sell | 1,900 @ $77.98 | $148,163 | 1,070,329 | 08/21/2024 | 08/23/2024 | |
|
Neumann Mark
EVP, Chief Commercial Officer |
Sell | 18,714 @ $75.08 | $1.41 M | 29,700 | 08/16/2024 | 08/20/2024 | |
|
RIGGS RORY B
Director |
Sell | 4,462 @ $75.57 | $337,193 | 116,600 | 06/24/2024 | 06/25/2024 | |
|
VAN NOSTRAND ROBERT L
Director |
Sell | 8,891 @ $75.71 | $673,138 | 20,799 | 06/18/2024 | 06/21/2024 | |
|
VAN NOSTRAND ROBERT L
Director |
Sell | 11,109 @ $76.07 | $845,062 | 9,690 | 06/18/2024 | 06/21/2024 | |
|
Mates Sharon
CEO |
Sell | 14,541 @ $64.80 | $942,257 | 1,056,333 | 03/11/2024 | 03/11/2024 | |
|
Mates Sharon
CEO |
Sell | 4,128 @ $65.90 | $272,035 | 1,052,205 | 03/11/2024 | 03/11/2024 | |
|
Mates Sharon
CEO |
Sell | 1,590 @ $66.81 | $106,228 | 1,050,615 | 03/11/2024 | 03/11/2024 | |
|
Mates Sharon
CEO |
Sell | 306 @ $67.33 | $20,603 | 1,050,309 | 03/11/2024 | 03/11/2024 | |
|
Hineline Lawrence J.
SVP of Finance, CFO |
Sell | 4,453 @ $65.28 | $290,692 | 1,129 | 03/11/2024 | 03/11/2024 | |
|
Hineline Lawrence J.
SVP of Finance, CFO |
Sell | 4,475 @ $66.47 | $297,453 | 64 | 03/11/2024 | 03/11/2024 | |
|
Hineline Lawrence J.
SVP of Finance, CFO |
Sell | 1,100 @ $66.54 | $73,194 | 29 | 03/11/2024 | 03/11/2024 | |
|
Hineline Lawrence J.
SVP of Finance, CFO |
Sell | 29 @ $67.32 | $1,952 | 0 | 03/11/2024 | 03/11/2024 | |
|
Hineline Lawrence J.
SVP of Finance, CFO |
Sell | 64 @ $67.12 | $4,296 | 0 | 03/11/2024 | 03/11/2024 | |
|
Halstead Michael
EVP and General Counsel |
Sell | 6,107 @ $65.82 | $401,963 | 1,238 | 03/11/2024 | 03/11/2024 | |
|
Halstead Michael
EVP and General Counsel |
Sell | 1,238 @ $66.70 | $82,575 | 0 | 03/11/2024 | 03/11/2024 | |
|
Neumann Mark
EVP, Chief Commercial Officer |
Sell | 4,303 @ $65.11 | $280,168 | 32,742 | 03/11/2024 | 03/11/2024 | |
|
Neumann Mark
EVP, Chief Commercial Officer |
Sell | 1,729 @ $65.92 | $113,976 | 31,013 | 03/11/2024 | 03/11/2024 | |
|
Neumann Mark
EVP, Chief Commercial Officer |
Sell | 1,313 @ $66.86 | $87,787 | 29,700 | 03/11/2024 | 03/11/2024 | |
|
Durgam Suresh K.
EVP, Chief Medical Officer |
Sell | 2,179 @ $65.06 | $141,766 | 21,336 | 03/11/2024 | 03/11/2024 |
Intra-Cellular Therapies, Inc. Congressional Trades History
| Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
|---|---|---|---|---|---|
| $82.47 | Sale | $1,001 - $15,000 | 07/09/2024 | 06/21/2024 |
Intra-Cellular Therapies, Inc. Frequently Asked Questions
-
Who is on Intra-Cellular Therapies, Inc.'s Insider Roster?
The list of insiders at Intra-Cellular Therapies, Inc. includes MARCUS JOEL S, Neumann Mark, Durgam Suresh K., Mates Sharon, Hineline Lawrence J., Halstead Michael, VAN NOSTRAND ROBERT L, RIGGS RORY B.
-
How much insider selling is happening at Intra-Cellular Therapies, Inc.?
Insiders have sold a total of 607,885 Intra-Cellular Therapies, Inc. shares in the last 12 months for a total of 44.20 M sold.
-
Which Intra-Cellular Therapies, Inc. insiders have been selling company stock?
The following insiders have sold Intra-Cellular Therapies, Inc. shares in the last 12 months: MARCUS JOEL S ($1.79 M), Neumann Mark ($3.32 M), Durgam Suresh K. ($864,193), Mates Sharon ($26.85 M), Hineline Lawrence J. ($2.47 M), Halstead Michael ($5.60 M), VAN NOSTRAND ROBERT L ($2.98 M), RIGGS RORY B ($337,193),